Qingfei Xiao

741 total citations
23 papers, 589 citations indexed

About

Qingfei Xiao is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Qingfei Xiao has authored 23 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 9 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Qingfei Xiao's work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers) and interferon and immune responses (6 papers). Qingfei Xiao is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers) and interferon and immune responses (6 papers). Qingfei Xiao collaborates with scholars based in China, United States and United Kingdom. Qingfei Xiao's co-authors include Guangyun Tan, Hongxiao Song, Fengchao Xu, Hongyue Wang, Rongli Piao, Genhong Cheng, Chenhao Li, Liming Yang, Ying Zhao and Pujun Gao and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Qingfei Xiao

23 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingfei Xiao China 14 206 176 136 136 99 23 589
Siavash Mansouri Iran 17 248 1.2× 215 1.2× 144 1.1× 63 0.5× 74 0.7× 23 784
Beili Xu China 12 175 0.8× 217 1.2× 89 0.7× 183 1.3× 122 1.2× 13 644
Shengnan Li China 15 230 1.1× 243 1.4× 66 0.5× 132 1.0× 140 1.4× 33 709
G Pisani Argentina 16 242 1.2× 164 0.9× 65 0.5× 105 0.8× 85 0.9× 41 749
Gabriela Viegas Haute Brazil 12 158 0.8× 185 1.1× 51 0.4× 126 0.9× 64 0.6× 29 526
Isidora Ranchal Spain 15 302 1.5× 319 1.8× 89 0.7× 251 1.8× 99 1.0× 27 903
Beihui He China 15 351 1.7× 335 1.9× 145 1.1× 68 0.5× 85 0.9× 43 863
Silvia Marchianò Italy 23 514 2.5× 429 2.4× 153 1.1× 207 1.5× 96 1.0× 57 1.5k
Kunissery A. Balasubramanian India 15 187 0.9× 234 1.3× 43 0.3× 190 1.4× 136 1.4× 24 764

Countries citing papers authored by Qingfei Xiao

Since Specialization
Citations

This map shows the geographic impact of Qingfei Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfei Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfei Xiao more than expected).

Fields of papers citing papers by Qingfei Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfei Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfei Xiao. The network helps show where Qingfei Xiao may publish in the future.

Co-authorship network of co-authors of Qingfei Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfei Xiao. A scholar is included among the top collaborators of Qingfei Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfei Xiao. Qingfei Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qu, Zhihui, et al.. (2023). Shenkang protects renal function in diabetic rats by preserving nephrin expression. BMC Complementary Medicine and Therapies. 23(1). 244–244. 6 indexed citations
2.
Xiao, Qingfei, Ying Zhao, Lei Ma, & Rongli Piao. (2022). Orientin reverses acetaminophen-induced acute liver failure by inhibiting oxidative stress and mitochondrial dysfunction. Journal of Pharmacological Sciences. 149(1). 11–19. 19 indexed citations
3.
Song, Hongxiao, Fengchao Xu, Qingfei Xiao, & Guangyun Tan. (2021). Hepatitis B virus X protein and its host partners. Cellular and Molecular Immunology. 18(5). 1345–1346. 21 indexed citations
4.
Xu, Fengchao, Hongxiao Song, Qingfei Xiao, et al.. (2021). Type-III interferon stimulated gene TRIM31 mutation in an HBV patient blocks its ability in promoting HBx degradation. Virus Research. 308. 198650–198650. 12 indexed citations
5.
Liu, Yafang, et al.. (2021). Clinical and pathological analysis of 101 cases of ANCA-associated vasculitic kidney injury. International Urology and Nephrology. 53(10). 2099–2106. 1 indexed citations
6.
Song, Hongxiao, Fengchao Xu, Xiaoli Pang, et al.. (2021). STAT3-Dependent Gene TRIM5γ Interacts With HBx Through a Zinc Binding Site on the BBox Domain. Frontiers in Microbiology. 12. 663534–663534. 4 indexed citations
7.
Xiao, Qingfei, Yan Cui, Yongli Zhao, et al.. (2020). Orientin relieves lipopolysaccharide-induced acute lung injury in mice: The involvement of its anti-inflammatory and anti-oxidant properties. International Immunopharmacology. 90. 107189–107189. 33 indexed citations
8.
Li, Chenhao, et al.. (2020). Hepatocyte Growth Factor Inhibits Renal Angiotensin II Expression in 5/6 Nephrectomized Rats.. PubMed. 50(5). 578–583. 1 indexed citations
9.
Lv, Xiaohong, Yazhen Li, Qingfei Xiao, & Dan Li. (2019). Daphnetin activates the Nrf2-dependent antioxidant response to prevent arsenic-induced oxidative insult in human lung epithelial cells. Chemico-Biological Interactions. 302. 93–100. 28 indexed citations
10.
Xu, Fengchao, et al.. (2019). NF-κB-Dependent IFIT3 Induction by HBx Promotes Hepatitis B Virus Replication. Frontiers in Microbiology. 10. 2382–2382. 19 indexed citations
11.
Wang, Lidong, Wei Wei, Qingfei Xiao, Huahong Yang, & Xinxin Ci. (2019). Farrerol Ameliorates APAP-induced Hepatotoxicity via Activation of Nrf2 and Autophagy. International Journal of Biological Sciences. 15(4). 788–799. 44 indexed citations
12.
Lv, Hongming, Qingfei Xiao, Junfeng Zhou, et al.. (2018). Licochalcone A Upregulates Nrf2 Antioxidant Pathway and Thereby Alleviates Acetaminophen-Induced Hepatotoxicity. Frontiers in Pharmacology. 9. 147–147. 70 indexed citations
13.
Xu, Fengchao, Hongxiao Song, Qingfei Xiao, et al.. (2018). Type III interferon-induced CBFβ inhibits HBV replication by hijacking HBx. Cellular and Molecular Immunology. 16(4). 357–366. 29 indexed citations
14.
Tan, Guangyun, Fengchao Xu, Hongxiao Song, et al.. (2018). Identification of TRIM14 as a Type I IFN-Stimulated Gene Controlling Hepatitis B Virus Replication by Targeting HBx. Frontiers in Immunology. 9. 1872–1872. 49 indexed citations
15.
Xiao, Qingfei, et al.. (2018). Orientin-mediated Nrf2/HO-1 signal alleviates H2O2-induced oxidative damage via induction of JNK and PI3K/AKT activation. International Journal of Biological Macromolecules. 118(Pt A). 747–755. 69 indexed citations
16.
Xiao, Qingfei, Yinghui Guan, Chenhao Li, et al.. (2018). Decreased expression of transforming growth factor-β1 and α-smooth muscle actin contributes to the protection of lotensin against chronic renal failure in rats. Renal Failure. 40(1). 583–589. 9 indexed citations
17.
Xiao, Qingfei, Zhihui Qu, Ying Zhao, Liming Yang, & Pujun Gao. (2017). Orientin Ameliorates LPS‐Induced Inflammatory Responses through the Inhibitory of the NF‐κB Pathway and NLRP3 Inflammasome. Evidence-based Complementary and Alternative Medicine. 2017(1). 2495496–2495496. 43 indexed citations
18.
19.
Sun, Liguang, Yue Hou, Qingfei Xiao, & Yujun Du. (2017). Association of serum sodium and risk of all-cause mortality in patients with chronic kidney disease: A meta-analysis and sysematic review. Scientific Reports. 7(1). 15949–15949. 43 indexed citations
20.
Zhang, Baohong, et al.. (2011). [The relationship between hyperuricaemia and clinic pathology of IgA nephropathy].. PubMed. 50(8). 659–63. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026